EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Evaluating the efficacy of immunochemoradiotherapy in malignant pleural mesothelioma and distinguishing benign from malignant lymph nodes using 18F-FDG PET/CT and 18F-FAPI-04 PET/CT imaging: A case report

Mengye Peng, Menglu Wang, Ying Zhang, Tingting Wu, Kezheng Wang

Advances in Radiotherapy & Nuclear Medicine · 2023

DOI: 10.36922/arnm.0963 ↗
AbstractBibliografische Angaben

Abstract

In this paper, we report a case of pleural mesothelioma, imaged employing 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT), and 18F-fibroblast activating protein inhibitor (FAPI)-04 PET/CT. The diagnosis of pleural mesothelioma was confirmed by histopathologically examining the thoracoscopic biopsy. The patient underwent an 18F-FDG PET/CT before immunochemoradiotherapy, followed by an 18F-FAPI-04 imaging 3 months after treatment. The changes in focal anatomy, morphology, and metabolic biology observed between the two distinct PET/CT imaging modalities can aid in distinguishing benign and malignant lymph nodes and assessing treatment efficacy. This case highlights the diagnostic utility of 18F-FDG PET/C in pleural mesothelioma and suggests that 18F-FAPI-04 PET/CT may serve as an effective tool for evaluating the outcomes of immunochemotherapy. Moreover, the combined application of 18F-FDG PET/CT and 18F-FAPI-04 PET/CT holds promise for the differentiation of benign and malignant lymph nodes.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →